Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 23, 2024

BUY
$47.98 - $54.4 $335 - $380
7 Added 0.14%
5,082 $275,000
Q4 2023

Jan 17, 2024

BUY
$48.48 - $57.85 $3,975 - $4,743
82 Added 1.64%
5,075 $260,000
Q3 2023

Oct 18, 2023

BUY
$57.89 - $64.73 $6,020 - $6,731
104 Added 2.13%
4,993 $289,000
Q2 2023

Jul 19, 2023

SELL
$63.71 - $70.74 $147,552 - $163,833
-2,316 Reduced 32.14%
4,889 $312,000
Q1 2023

Apr 17, 2023

BUY
$65.71 - $74.53 $4,008 - $4,546
61 Added 0.85%
7,205 $499,000
Q4 2022

Jan 20, 2023

BUY
$68.48 - $81.09 $1,301 - $1,540
19 Added 0.27%
7,144 $0
Q3 2022

Oct 21, 2022

BUY
$0.13 - $76.84 $19 - $11,295
147 Added 2.11%
7,125 $507,000
Q2 2022

Jul 22, 2022

SELL
$72.62 - $79.98 $2,033 - $2,239
-28 Reduced 0.4%
6,978 $537,000
Q1 2022

Apr 20, 2022

BUY
$61.48 - $73.72 $1,537 - $1,843
25 Added 0.36%
7,006 $511,000
Q4 2021

Jan 21, 2022

BUY
$53.63 - $62.52 $2,413 - $2,813
45 Added 0.65%
6,981 $435,000
Q3 2021

Oct 19, 2021

SELL
$59.17 - $69.31 $6,922 - $8,109
-117 Reduced 1.66%
6,936 $410,000
Q2 2021

Jul 23, 2021

BUY
$61.91 - $67.42 $3,405 - $3,708
55 Added 0.79%
7,053 $471,000
Q1 2021

Apr 20, 2021

BUY
$59.34 - $66.74 $129,598 - $145,760
2,184 Added 45.37%
6,998 $442,000
Q4 2020

Jan 28, 2021

BUY
$57.74 - $65.43 $173 - $196
3 Added 0.06%
4,814 $299,000
Q3 2020

Oct 21, 2020

BUY
$57.43 - $63.64 $172 - $190
3 Added 0.06%
4,811 $290,000
Q2 2020

Jul 31, 2020

BUY
$54.82 - $64.09 $2,960 - $3,460
54 Added 1.14%
4,808 $283,000
Q1 2020

May 01, 2020

SELL
$46.4 - $67.43 $5,289 - $7,687
-114 Reduced 2.34%
4,754 $264,000
Q4 2019

Jan 17, 2020

BUY
$49.21 - $64.19 $10,383 - $13,544
211 Added 4.53%
4,868 $313,000
Q3 2019

Oct 11, 2019

SELL
$42.77 - $50.71 $18,733 - $22,210
-438 Reduced 8.6%
4,657 $236,000
Q2 2019

Jul 18, 2019

BUY
$44.62 - $49.34 $45,244 - $50,030
1,014 Added 24.85%
5,095 $231,000
Q1 2019

Apr 17, 2019

BUY
$45.12 - $53.8 $135 - $161
3 Added 0.07%
4,081 $195,000
Q4 2018

Jan 18, 2019

BUY
$48.76 - $63.23 $146 - $189
3 Added 0.07%
4,078 $212,000
Q3 2018

Oct 12, 2018

BUY
$55.19 - $62.25 $165 - $186
3 Added 0.07%
4,075 $253,000
Q2 2018

Jul 18, 2018

BUY
$50.53 - $62.98 $151 - $188
3 Added 0.07%
4,072 $225,000
Q1 2018

May 11, 2018

SELL
$59.92 - $68.98 $17,856 - $20,556
-298 Reduced 6.82%
4,069 $257,000
Q4 2017

Jan 16, 2018

BUY
$59.94 - $65.35 $39,140 - $42,673
653 Added 17.58%
4,367 $268,000
Q3 2017

Oct 12, 2017

BUY
$55.23 - $63.74 $205,124 - $236,730
3,714
3,714 $237,000

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $113B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Gemmer Asset Management LLC Portfolio

Follow Gemmer Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gemmer Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gemmer Asset Management LLC with notifications on news.